The fast-paced changes in hepatitis C treatment are being watched closely amid fears that breakthrough drugs could reignite the rise of U.S. health-care costs. Source: www.seattletimes.com
Someday, treating patients with nanorobots could become standard practice to deliver medicine specifically to parts of the body affected by disease. But merely injecting drug-loaded nanoparticles might […]
Americans are flocking to online video as a source of information and entertainment like never before. According to comScore, a technology company that measures how people […]
If pharmaceutical and medical device companies are on the fence about how to incorporate social media into their digital marketing campaigns, they better get moving. The reason is […]
Les agences française (ANSM) et européenne (EMA) réévaluent les rapports bénéfice/risque des produits de santé afin de prendre des mesures de gestion efficaces et rapides face […]